Skip to content

The effect of Uncut Roux-en-Y Alimentary Reconstruction and Billroth II Alimentary Reconstruction on the Long-term Complications and quality of life after Laparoscopic D2 radical gastrectomy for distal gastric cancer: A Single center, open, superiority of randomized controlled Clinical Trial

The effect of Uncut Roux-en-Y Alimentary Reconstruction and Billroth II Alimentary Reconstruction on the Long-term Complications and quality of life after Laparoscopic D2 radical gastrectomy for distal gastric cancer: A Single center, open, superiority of randomized controlled Clinical Trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-IOR-17013072
Enrollment
Unknown
Registered
2017-10-21
Start date
2018-07-01
Completion date
Unknown
Last updated
2018-07-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

gastric cancer

Interventions

A:uncut Roux-en-y anastomosis
B:Billroth II anastomosis

Sponsors

The Affiliated Hospital of Guangdong Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: (1) Pathological diagnosis clearly, by the surgeon and imaging physician to assess the possibility of resection; (2) no history of other malignancies; (3) has signed the patient informed consent; (4) Aged 18 to 80 years old, male or female patient; (5) cardiopulmonary liver and kidney function was normal, ECOG physical condition score of 0 to 1 points.

Exclusion criteria

Exclusion criteria: (1) pregnant or lactating women; (2) liver, lung, bone, and other distant metastasis; (3) supraclavicular lymph nodes, pelvic floor or ovarian species, peritoneal spread; (4) a lot of ascites, cachexia; (5) suffering from other serious diseases, including cardiovascular, respiratory, kidney, or liver disease, combined with poor control of hypertension, diabetes patients; (6) mental disorders or diseases; (7) patients who have participated in or are participating in other clinical trials within the first 4 weeks of enrollment; (8) patients who have undergone surgery and whose effects have not been eliminated; (9) history of gastric or esophageal malignancies, including stromal tumors, sarcoma, lymphoma, carcinoid; (10) combined with active infection in patients (infection caused by fever above 38 degree C); (11) patients with poor compliance or the researchers considered poor patient compliance; (12) With other clinical and laboratory conditions that the investigators believe should not participate in the trial.

Design outcomes

Primary

MeasureTime frame
Reflux gastritis;

Countries

China

Contacts

Public ContactXu Qingwen

The Affiliated Hospital of Guangdong Medical University

xuqwen@tom.com+86 13600387083

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026